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Available online 13 October 2009StAPs are potato aspartic proteases with cytotoxic activity against plant pathogens and
spermatozoa. StAPs cytotoxic activity is selective, since these proteins do not exert toxic effect
on plant cells and erythrocytes. In this work, we investigated the capacity of StAPs to exert
cytotoxicity on human leukaemia cells. Obtained results show that StAPs induce apoptosis on
Jurkat T cells after a short time of incubation in a dose-dependent manner. However, no
significative effect on the T lymphocytes viability was observed at all StAPs incubation times
and concentrations tested. These results suggest that StAPs can be conceptually promising
leads for cancer therapy.







Antimicrobial proteins and peptides (AMPPs) are impor-
tant components of the natural defences of most living
organisms against invading pathogens and are found in a
wide range of eukaryotic organisms, from humans to plants
[1–7]. The discovery of new groups of AMPPs as potential
natural antibiotics represents a hit toward the discovery of a
novel generation of drugs for the treatment of bacterial and
fungal infections [8,9]. Moreover, the broad spectrum of
antimicrobial activities reported for these molecules suggests
their potential benefit in the treatment of viral or parasitic
infections [10,11] and cancer [12–14]. In contrast to conven-
tional antibiotics, they act by physical disturbance or
destruction of the barrier function of the plasma membrane
cell without involvement of a specific receptor [15,16]. Some
have been successfully used to eliminate, e.g., prostate tumor
cells in vitro [17], and others were also very effective in vivo inrotease; AP, Aspartic
.
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ara).
All rights reserved.the eliminationof leukaemia, ascite andovarian tumors [18,19].
In plants, in vitro antimicrobial activity has been demonstrated
for the following peptides and proteins: (i) some of the so-
called pathogenesis-related proteins, which were originally
identified as pathogen-elicited proteins [20,21]; and (ii) a
number of plant antimicrobial protein and peptide families
[22]. Furthermore, plant proteins and peptides with cytotoxic
activity and anticancer properties in vitro on human cancer cell
lines have been reported [23–30].
Aspartic proteases (EC 3.4.23) (AP) are a class of widely
distributed proteases present in animals, microbes, viruses
and plants [31,32]. Biological functions of plant APs have not
been characterized as those of their mammalian, microbial or
viral counterparts [31–33]. Previously, we have studied the
biochemical properties, the pattern of expression and the
biological functions of potato aspartic proteases (StAPs:
Solanum tuberosum aspartic proteases, Merops family A1)
[34,35]. We have identified three StAPs: one from tuber
(StAP1) and two from leaves (StAP2 and StAP3). Two of these
isoforms, StAP1 and StAP3, have been purified and charac-
terized [34,35]. Both proteins are induced by abiotic and
biotic stresses, and have extracellular localization and
antimicrobial activity towards potato pathogens [35–37].
The mechanism of action of StAPs, as well as other AMPPs,
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membrane disruption and cell death [38]. Both StAPs act as
spermicidal compound inducing plasma membrane destabi-
lization and cell death on bovine and human spermatozoa,
but no harmful effect was reported on human erythrocytes
[39]. Based on these results and with results reported for
other AMPPs, we speculate that StAPs could have antitumoral
activity. In the present work, we therefore tested the
cytotoxic effect of StAP1 and StAP3 on Jurkat T cells, a
human leukaemia cell line, and on freshly isolated, non-
transformed human peripheral T lymphocytes. Our results
show that StAP1 and StAP3 cause both apoptotic and necrotic
effects on Jurkat T cells; however, no significant effect was
detected on non-transformed T lymphocytes.
2. Materials and methods
2.1. Cells and in vitro culture
Jurkat T-leukaemia cells were grown in suspension and
propagated in Roswell Park Memorial Institute (RPMI)
medium 1640 supplemented with 10% (v/v) heat-inactivated
fetal bovine serum (all obtained from Sigma, St Louis, MO). To
maintain exponential growth, the cultureswere divided every
third day by dilution to a concentration of 1×105 cells/ml.
Blood samples (20 ml) were obtained from AVIS (Italian
Association of Voluntary Blood Donors); donors provide
written, informed consent for the study and use of samples
at the time of donation. Human mononuclear cells were
isolated by density gradient centrifugation using Ficoll-
Hypaque (Pharmacia Biotech, Uppsala, Sweden). Lymphocyte
cells were cultured in RPMI 1640, containing 10% (v/v) heat-
inactivated fetal bovine serum, and 5 µg/ml phytohemag-
glutinin (PHA; Sigma). Jurkat T cells and T lymphocyte cells
were incubated at 37 °C, 5% CO2. After PHA stimulation, >90%
was activated T cells [40].
2.2. Protein purification
The Balcarce Experimental Station of the Instituto National
de Tecnología Agropecuaria (INTA), Argentina, provided potato
tubers (S. tuberosum L. cv. Pampeana). S. tuberosum L. cv.
Pampeana INTA (MPI 59.789/12×Huinkul MAG) is a cultivar
from the Argentine Breeding Program (INTA-Balcarce).
Sterile disks (10 mmdiameter, 2 mmthick) of potato tuber
(S. tuberosum L. cv. Pampeana INTA) were prepared, washed
extensively, suspended in sterilewater (15 diskswith 23 ml of
water) and aerated for 24 h at 25 °C in an orbital shaker at
60 cycles/min. StAP1 was purified using a Q-Sepharose Fast
Flow ion exchange chromatography column followed by a
Sepharose–pepstatin A affinity column as previously de-
scribed [34].
Potato leaves (S. tuberosum L. cv. Pampeana INTA) were
detached and were placed at 18 °C in a moist chamber. StAP3
was purified using a Q-Sepharose Fast Flow ion exchange
chromatography column, followed by a Sepharose–pepstatin
A affinity column as previously described [35].
The purity of proteins was checked by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) using
15% acrylamide gels [41]. Gels were stainedwith silver nitrate
[42].2.3. Cytotoxicity test
Viability was determined using Trypan blue dye-exclusion
test, which distinguishes viable and non-viable cells [43].
Jurkat cells and T lymphocytes were treated with different
concentrations of StAP1, StAP3 or bovine serum albumin
(BSA) (0.25 µM, 1.5 µM, 1.8 µM, and 3.75 µM) for 24 and 48 h
respectively (i.e. the exposure times correspond to the length
of the cell-cycle for Jurkat T cells and T lymphocytes). Results
were calculated as viable cells in StAPs-treated cultures
relative to control. Concentration causing cell toxicity by
50% following one cell-cycle exposure (i.e. IC50) was
calculated by interpolation from dose–response curves.
2.4. Flow cytometry
Micro-flow cytometric analysis was performed using the
Agilent Bioanalyzer 2100 (Agilent Technologies, Palo Alto, CA,
USA) with the cell assay extension. For cell assays, individual
cell fluorescence intensities were measured at two wave-
length channels (excitation wavelength 470 nm/emission
wavelength 525 nm and excitation wavelength 635 nm/
emission wavelength 680 nm). The loading of the micro-
fluidics chip was performed according to the manufacturer's
recommendations. Briefly, after pre-treatment of the chip
with 10 µl of priming solution (Cell Fluorescence LabChip Kit,
Agilent), a focusing dye solution (LabChip Kit) was applied to
the appropriate well of the LabChip for adjustment of the
Bioanalyzer optics to each individual chip. Prior to loading of
samples, two aliquots (30 µl each) of Cell Buffer were
pipetted into the appropriate wells. A total of 6 individual
samples with a volume of 10 µl each were analyzed, on each
chip.
2.5. Evaluation of apoptosis and necrosis by flow cytometry
Cells of exponentially growing cultures were collected at a
time corresponding to one cell-cycle (24 h for Jurkat T cells
and 48 h for T lymphocytes). In order to evaluate if the
apoptotic and necrotic effects of StAPs require either acute
(hours) or continuous (days) exposures to each compound, a
shorter (6 h for Jurkat T cells and 24 h for T lymphocytes) and
a longer (48 h for Jurkat T cells and 72 h for T lymphocytes)
time-points were studied.
After treatment, cells were centrifuged (100×g) for
10 min, resuspended at a density of 1×106cells/ml in 500 µl
of medium containing 10 µl of Media Binding Reagent (Merck
KGaA, Darmstadt, Germany) and 1.25 µl of Annexin V–biotin
(Merck KGaA) and incubated for 15 min. After washing, cells
were resupended in 500 µl of Binding Buffer (Merck KGaA)
and treatedwith 1 µl of Cy-5-labelled streptavidine (1 mg/ml,
GE Healthcare Biosciences, Uppsala, Sweden) and 0.5 µl of
calcein 500 µM (Molecular Probes). After 30 min, the cells
were centrifuged and resuspended in Cell Buffer (Agilent
Technologies). The chip was prepared for the flow cytometric
measurements as described above.
2.6. Statistical analysis
All data are the mean+S.E. of at least three experiments.
Statistical significance of the results was evaluated using
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t-test (SigmaStat 3.0). Differences between values were
considered statistically significant if P<0.001.
3. Results
The effect of StAPs on Jurkat T and T lymphocyte cells
viability was analyzed by Trypan blue dye-exclusion test [43].
Fig. 1 shows the growth curves of Jurkat T cells and T
lymphocytes after incubation with different amounts of
StAPs. Both proteins were able to cause a dose-dependent
decrease on the Jurkat T cells viability percentage. The IC50
values were determined by interpolation from the dose–
response curves. For StAP1 and StAP3 IC50 values were i.e.
2.0 µM and 2.5 µM for StAP1 and StAP3 respectively. However
the maximal cytotoxic effect of StAP3 was greater (80%) than
the effect of StAP1 (60%) on Jurkat T cells viability, at the
highest concentration assayed (4 µM). The cytotoxicity of
these proteins on T lymphocyte cells was lower than that
observed on Jurkat T cells, at all concentrations assayed.
StAP1 and StAP3 were able to produce a reduction of 20% and
30%, respectively, in the viability of T lymphocyte cells at the
highest concentration assayed (4 µM).
Changes in cell morphology were analyzed by microscopy.
Only in Jurkat T cells at highest StAP concentrations, plasma
membrane disruption and release of cytoplasm were observed
(data not shown). No significant decreases in the cells viability
were observed when Jurkat T cells and T lymphocytes were
incubated with different amounts of BSA (data not shown).Fig. 1. The effects of StAP1 (A) and StAP3 (B) on viability of Jurkat T cells and T lym
cultures after one cell-cycle. The data presented are average from three independenUsing flow cytometry we quantified the percentage of
calceinepositive cells (i.e. necrotic cells), to determine the
percentage of necrotic cells (Jurkat T cells and T lymphocytes)
after incubation with StAPs. Cells were incubated with
different amounts of StAPs for a time corresponding to one
cell-cycle, i.e. 24 h for Jurkat T cells, 48 h for T lymphocytes.
Additionally, a shorter (6 h for Jurkat T cells and 24 h for T
lymphocytes) and a longer (48 h for Jurkat T cells and 72 h for
T lymphocytes) times were analyzed. Results obtained
demonstrate that StAPs (StAP1, Fig. 2; and StAP3, Fig. 3)
were able to induce cell necrosis in Jurkat T cells, in a dose-
dependent manner, at all times and concentrations assayed.
No significant increases in the necrotic cells percentage with
respect to the control were observed in T lymphocyte cells at
all times and StAP concentrations assayed (Figs. 2D,E,F and
3D,E,F). At shortest incubation time, StAPs induce, in Jurkat T
cells, a dose-dependent increase in the fraction of necrotic
cells. Low concentrations of StAP1 (Fig. 2A) and StAP3
(Fig. 3A) were able to increase by 15% and 27% the percentage
of necrotic cells, respectively. At the highest concentration of
StAPs assayed (3.75 µM), an increase in the necrotic cells of
55% approximately, was observed (Figs. 2A and 3A). After
24 h of incubation, the start of statistically significant
increases in the percentage of necrotic cells was observed at
0.25 µM to StAP1 and 1.5 µM to StAP3. An increase in the
percentages of necrotic cells was observed at 3.75 µM of
StAPs, with respect to these percentages at short time (60%
and 82% to StAP1 and StAP3 respectively) (Figs. 2B and 3B).
No significant increases in the percentages of necrotic cellsphocytes. Cells were removed from protein-treated and untreated (control)
t experiments, with error bars denoting standard errors.
Fig. 2. Fraction of viable cells (filled bars) and necrotic cells (clear bars), as detected in Jurkat T cells (A, B, and C) and T lymphocytes (D, E, and F) treated with StAP1
at the indicated doses for 6, 24 and 48 h for Jurkat T cells (A, B and C respectively) and for 24, 48 and 72 h for T lymphocytes (D, E and F respectively). Cells were
removed from treated and untreated cultures and stained with Annexin V–Cy-5 and calcein. The data presented are average from three independent experiments,
with bars denoting standard error. ⁎P<0.001 with respect to the controls.
332 J.R. Mendieta et al. / Fitoterapia 81 (2010) 329–335were observed, with respect to the control, in T lymphocytes
treated with StAPs for 24 h (Figs. 2D and 3D); 48 h (Figs. 2E
and 3E) and 72 h (Figs. 2F and 3F), at all concentrations
assayed. No effects on the necrotic cell percentages were
detected in Jurkat T cells and T lymphocytes treated with BSA
(data not shown).
In order to analyze the induction of apoptosis of Jurkat T
and T lymphocyte cells, the percentages of Annexin Vpositive–
calceinnegative cells (i.e. apoptotic cells) were measured by
flow cytometry. Assays were performed incubating Jurkat T
and T lymphocyte cells with different amounts of StAPs
during 6, 24 and 48 h for Jurkat T cells and 24, 48 and 72 h for
T lymphocytes. Table 1 shows that, StAPs induce apoptosis in
a dose-dependent manner only in Jurkat T cells, at all times
assayed, with respect to the percentage of apoptotic cells
determined in the controls. Moreover, in Jurkat T cells, StAP1
caused apoptosis after 6 h of treatment, whereas StAP3
caused that effect at 6 h (Table 1) and 24 h (data not
shown) of incubation. After 6 h of treatment at 3.75 µM of
StAPs, the percentage of apoptotic Jurkat T cells was 26.6%for StAP1 and 34.11% for StAP3 (versus 6.8% and 4.4% in the
controls respectively). On the other hand, the incidence of
apoptotic T lymphocytes at 24 h of incubation at all doses of
StAPs assayed was not significantly different to the control
(Table 1). No increases in the induction of apoptosis were
detected in Jurkat T cell and T lymphocyte cultures treated
with BSA (data not shown).
4. Discussion
Several studies on AMPPs have focused in their putative
antitumoral activities on human and mammalian cancer cell
lines in vitro [8–10,17–19,44–46]. In consequence, they have
been characterized as alternative compounds to be employed
in cancer treatment and/or prevention [8–10]. We have
previously reported that StAPs have cytotoxic activity against
potato pathogens and human and bovine spermatozoa
[36,37]. We have demonstrated that cytotoxic activity of
StAPs involves plasma membrane permeabilization and,
subsequently, cell death [38,39]. In this work we show that
Fig. 3. Fraction of viable cells (filled bars) and necrotic cells (clear bars), as detected in Jurkat T cells (A, B, and C) and T lymphocytes (D, E, and F) treated with StAP3
at the indicated doses for 6, 24 and 48 h for Jurkat T cells (A, B and C respectively) and for 24, 48 and 72 h for T lymphocytes (D, E and F respectively). Cells were
removed from treated and untreated cultures and stained with Annexin V–Cy-5 and calcein. The data presented are average from three independent experiments
with bars denoting standard error. ⁎P<0.001 with respect to the controls.
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human leukaemia cell line. StAPs were able to produce
significant dose-dependent decreases in the percentage of
viable Jurkat T cells, whereas only a slight decrease was
detected in the viability of non-transformed T cells. Also, cellTable 1
Incidence of apoptosis in Jurkat T cells and T lymphocytes treated with




Jurkat T (6 h) Lymphocytes (24 h)
StAP1 Control 6.80±0.80 4.30±0.20
0.25 8.03±1.20 5.30±0.30
1.50 19.42±6.20 ⁎ 4.10±0.80
1.80 18.00±7.80 ⁎ 3.80±0.70
3.75 26.60±7.40 ⁎ 4.20±0.40
StAP3 Control 4.40±0.60 6.50±0.80
0.25 8.80±1.20 ⁎ 6.10±1.50
1.50 10.24±1.50 ⁎ 7.10±2.30
1.80 19.95±1.40 ⁎ 5.90±3.40
3.75 34.11±0.30 ⁎ 6.30±6.50
⁎ P<0.001 with respect to the control.morphology alterations were also observed in Jurkat T cells
incubated with different amounts of StAPs. These changes
involve plasma membrane disruption and release of cyto-
plasm (data not shown). The StAP concentrations needed to
reduce Jurkat T cell viability by 50% were in the same order of
magnitude than those previously reported for plant peptides
and proteins active against human tumor cells [23,47–49].
The results herein obtained show that StAPs were able to
produce necrosis in dose-dependent manner on Jurkat T cells,
while this effect was not exerted on T lymphocytes.
Additionally, we show that StAPs induce apoptosis only on
Jurkat T cells after short times of incubation at the highest
concentration assayed; however, no significative apoptosis
induction was observed on T lymphocytes at any time and
StAP concentrations assayed. These results are in accordance
with previous reports showing that the capacity of many
antitumoral compounds to cause necrosis or apoptosis in
vitro could depend on the doses and/or the time of
treatments. That is, some drugs could induce necrosis at
high doses and prolonged times of treatment or alternatively,
could induce apoptosis at a short time of treatment or
subnecrotic doses [50–52]. The capacity of StAPs to induce
334 J.R. Mendieta et al. / Fitoterapia 81 (2010) 329–335apoptosis on human leukaemia Jurkat T cells provides an
interesting starting point for further investigations on the
molecular mechanisms underlying that effect, as well as on
the suitable conditions to induce programmed cell death
without necrosis, which consequently produces an inflam-
matory process.
Because selective targeting for cancer cells is a fundamen-
tal requisite for potential chemotherapy agents, the lack of
haemolytic activity of StAPs in vitro [39] and its no
significative cell toxicity on non-transformed T lymphocytes,
could be important features. However, more assays involving
other cell lines should be performed.
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